Growth Metrics

Quest Diagnostics (DGX) Income towards Parent Company: 2009-2024

Historic Income towards Parent Company for Quest Diagnostics (DGX) over the last 16 years, with Dec 2024 value amounting to $867.0 million.

  • Quest Diagnostics' Income towards Parent Company rose 7.54% to $214.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $844.0 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $867.0 million for FY2024, which is 2.36% up from last year.
  • According to the latest figures from FY2024, Quest Diagnostics' Income towards Parent Company is $867.0 million, which was up 2.36% from $847.0 million recorded in FY2023.
  • Quest Diagnostics' 5-year Income towards Parent Company high stood at $2.0 billion for FY2021, and its period low was $847.0 million during FY2023.
  • In the last 3 years, Quest Diagnostics' Income towards Parent Company had a median value of $867.0 million in 2024 and averaged $882.7 million.
  • In the last 5 years, Quest Diagnostics' Income towards Parent Company skyrocketed by 5,384.62% in 2020 and then slumped by 52.42% in 2022.
  • Yearly analysis of 5 years shows Quest Diagnostics' Income towards Parent Company stood at $1.4 billion in 2020, then surged by 42.87% to $2.0 billion in 2021, then tumbled by 52.42% to $934.0 million in 2022, then declined by 9.31% to $847.0 million in 2023, then climbed by 2.36% to $867.0 million in 2024.